View Older Stories View More Recent Stories
-
Sage Therapeutics (SAGE) PT Raised to $112 at BMO Capital on PPD and MDD Opportunities
-
scPharmaceuticals Inc. Prices 6.4M Share IPO at $14/Sh
-
BMO Capital Upgrades Anadarko Petroleum (APC) to Outperform
-
scPharmaceuticals Inc. Announces Pricing of Initial Public Offering
-
Canadian dollar edges higher, boosted by manufacturing sales gain
-
Pre-Open Movers 11/16: (TIME) (RH) (NTAP) (CSCO) (WMT) Higher; (AXGN) (LB) (APPN) Lower (more...)
-
Cisco (CSCO) PT Raised to $36 at BMO Capital
-
Sally Beauty Holdings (SBH): Waiting For Rightsizing Benefits - BMO
-
BMO Capital Upgrades NetApp (NTAP) to Outperform
-
BMO Capital Upgrades Pandora (P) to Outperform
-
Sally Beauty Holdings (SBH) PT Lowered to $16 at BMO Capital Following 4Q
-
UPDATE: CORRECTION: BMO Capital Starts VBI Vaccines (VBIV) at Outperform
-
Flowers Foods (FLO) PT Raised to $20 at BMO Capital Following Investor Meetings with CFO
-
Financial 15 Split Corp. Completes Overnight Offering of $109,364,400
-
Halozyme Therapeutics To Participate In Upcoming Healthcare Conferences
-
BMO Capital Downgrades TreeHouse Foods (THS) to Market Perform
-
UPDATE: BMO Capital Starts Corporate Capital Trust (CCT) at Market Perform
-
BMO Capital Starts Fortive (FTV) at Outperform, 'Operating at a Higher Level'
-
Tyson (TSN) PT Raised to $89 at BMO Capital on 3Q Report; 'Stellar Beef Packer Margins'
-
J. C. Penney (JCP) PT Raised to $3.25 at BMO Capital on 3Q Report; 'Long-Standing Challenges in Women's Apparel Still Loom'
-
UPDATE: BMO Capital Downgrades Statoil ASA (STO) to Market Perform Citing A Pending Slowdown in 2018 Operations
-
Switch (SWCH) Guidance Looks Conservative - BMO Capital
-
Fine-Tuned Portfolios and Business Models Stand to Help Retailers Adapt to Change, Says Joe McKeska of Elkhorn Real Estate Partners
-
Valeant Pharma (VRX): Raising PT To $17 But Not Rating...Yet - BMO
-
Pfizer (PFE) Should Buy Biogen (BIIB) Instead - BMO
-
Five Prime Therapeutics (FPRX): Buy on Weakness - BMO
-
Incyte (INCY): Thoughts From BMS-986205 Trial Data - BMO
-
BMO Capital Upgrades NVIDIA (NVDA) to Market Perform, 'Our Underperform Call Did Not Work Out'
-
BMO Capital Upgrades The Chefs' Warehouse, Inc (CHEF) to Outperform, 'Executing Well'
-
SpartanNash Company (SPTN) PT Lowered to $22 at BMO Capital
-
Humana (HUM) PT Lowered to $290 at BMO Capital on 3Q Report; 'Increased Competition in Medicare'
-
Coty Inc. (COTY) PT Lowered to $22 at BMO Capital on 1Q18 Report; 'Higher Confidence in Turnaround Story'
-
Amphastar Pharmaceuticals (AMPH) PT Raised to $17 at BMO Capital on 3Q Report; 'Awaiting Execution With Key Pipeline Opportunities'
-
NVIDIA (NVDA) PT Raised to $135 at BMO Capital, Remains Underperform
-
Brandywine Realty Trust Prices $100.0 Million of 3.950% 5-Year Guaranteed Notes and $450.0 Million of 3.950% 10-Year Guaranteed Notes
-
Form 13F-NT BMO CAPITAL MARKETS CORP For: Sep 30
-
Sage Therapeutics (SAGE) Hits 'Very Significant Milestone' - BMO
-
Pilgrim's Pride (PPC) PT Raised to $38 at BMO Capital on 3Q Beat; 'Better than Expected Mexican Margins, Strong U.S. Performance'
-
Pacira Pharmaceuticals (PCRX) PT Raised to $39 at BMO Capital on 3Q Report; 'Higher Gross Margin and Lower R&D'
-
Monster Beverage (MNST) PT Raised to $65 at BMO Capital on 3Q Report; 'Sales Momentum Appears to be Broad-Based'
-
Global Payments (GPN) PT Raised to $115 at BMO Capital on 3Q Report; 'Business Model Shines'
-
e.l.f. Beauty, Inc. (ELF): Category Slowdown WeighS on Results - BMO
-
Match Group (MTCH) PT Raised to $35 at BMO Capital
-
B&G Foods Announces Pricing and Upsizing of Public Offering of Senior Notes
-
InflaRx (IFRX) IPO Opens Flat
-
Financial 15 Split Corp. Announces Successful Overnight Offering
-
B&G Foods Announces Public Offering of Senior Notes
-
Osisko Gold Royalties Reports Third Quarter 2017 Results
-
InflaRx Announces Pricing of Initial Public Offering
-
Aeglea BioTherapeutics Provides Corporate Update and Reports Third Quarter 2017 Financial Results

